• Info
  • Insider Ownership

Insider Trading & Ownership of Abraham Ceesay

Location
Burlington, MA
Summary
The estimated net worth of Abraham Ceesay is at least $23.1M dollars as of 18 Dec 2025. Abraham Ceesay is the Chief Executive Officer, Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $20.9M. Abraham Ceesay is the President of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. stock worth about $1.23M. Abraham Ceesay is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $570K. Abraham Ceesay is the Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and owns shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock worth about $409K.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Abraham Ceesay files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Abraham Ceesay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Executive Officer, Director $20.9M -$2.89M -12.1% 17 Dec 2025
CERE Cerevel Therapeutics Holdings, Inc. President $1.23M 06 Feb 2023
PCRX Pacira BioSciences, Inc. Director $570K -$64K -10.1% 04 Sep 2025
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director $409K 02 Jun 2025

Insider Transactions Reported by Abraham Ceesay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.